Latest Altium Capital Management LP Stock Portfolio
$252Million– No. of Holdings #68
Altium Capital Management LP Performance:
2024 Q1: 16.12%YTD: 16.12%2023: 9.7%
Performance for 2024 Q1 is 16.12%, and YTD is 16.12%, and 2023 is 9.7%.
About Altium Capital Management LP and 13F Hedge Fund Stock Holdings
In it's latest 13F Holdings report, Altium Capital Management LP reported an equity portfolio of $252.7 Millions as of 31 Mar, 2024.
The top stock holdings of Altium Capital Management LP are VERA, XENE, AXSM. The fund has invested 12.1% of it's portfolio in VERA THERAPEUTICS INC and 5.9% of portfolio in XENON PHARMACEUTICALS INC.
The fund managers got completely rid off EA SERIES TRUST (BOB), IMMUNOVANT INC (IMVT) and CYMABAY THERAPEUTICS INC (CBAY) stocks. They significantly reduced their stock positions in ASTRIA THERAPEUTICS INC (ATXS), ORIC PHARMACEUTICALS INC (ORIC) and MARINUS PHARMACEUTICALS INC (MRNS). Altium Capital Management LP opened new stock positions in AVADEL PHARMACEUTICALS PLC (AVDL), BIOHAVEN LTD and VIKING THERAPEUTICS INC (VKTX). The fund showed a lot of confidence in some stocks as they added substantially to RHYTHM PHARMACEUTICALS INC (RYTM), INTRA-CELLULAR THERAPIES INC (ITCI) and NEUROGENE INC.
The top stock holdings of Altium Capital Management LP are VERA, XENE, AXSM. The fund has invested 12.1% of it's portfolio in VERA THERAPEUTICS INC and 5.9% of portfolio in XENON PHARMACEUTICALS INC.
The fund managers got completely rid off EA SERIES TRUST (BOB), IMMUNOVANT INC (IMVT) and CYMABAY THERAPEUTICS INC (CBAY) stocks. They significantly reduced their stock positions in ASTRIA THERAPEUTICS INC (ATXS), ORIC PHARMACEUTICALS INC (ORIC) and MARINUS PHARMACEUTICALS INC (MRNS). Altium Capital Management LP opened new stock positions in AVADEL PHARMACEUTICALS PLC (AVDL), BIOHAVEN LTD and VIKING THERAPEUTICS INC (VKTX). The fund showed a lot of confidence in some stocks as they added substantially to RHYTHM PHARMACEUTICALS INC (RYTM), INTRA-CELLULAR THERAPIES INC (ITCI) and NEUROGENE INC.
Altium Capital Management LP Equity Portfolio Value
Last Reported on: 15 May, 2024
Altium Capital Management LP Annual Return Estimates Vs S&P 500
Our best estimate is that Altium Capital Management LP made a return of 16.12% in the last quarter. In trailing 12 months, it's portfolio return was 28.64%.
New Buys
| Ticker | $ Bought |
|---|---|
| avadel pharmaceuticals plc | 9,341,130 |
| biohaven ltd | 7,656,600 |
| viking therapeutics inc | 6,970,000 |
| cybin inc | 5,769,770 |
| larimar therapeutics inc | 5,275,050 |
| mirum pharmaceuticals inc | 5,224,960 |
| praxis precision medicines i | 4,765,660 |
| achieve life sciences inc | 3,797,210 |
New stocks bought by Altium Capital Management LP
Additions
| Ticker | % Inc. |
|---|---|
| rhythm pharmaceuticals inc | 783 |
| intra-cellular therapies inc | 59.15 |
| neurogene inc | 49.3 |
| olema pharmaceuticals inc | 46.27 |
| soleno therapeutics inc | 45.75 |
| adma biologics inc | 40.64 |
| catalyst pharmaceuticals inc | 29.87 |
| xenon pharmaceuticals inc | 19.78 |
Additions to existing portfolio by Altium Capital Management LP
Reductions
| Ticker | % Reduced |
|---|---|
| astria therapeutics inc | -80.48 |
| oric pharmaceuticals inc | -40.09 |
| marinus pharmaceuticals inc | -11.58 |
| xtant med hldgs inc | -4.73 |
| alimera sciences inc | -4.14 |
| alpine immune sciences inc | -1.11 |
Altium Capital Management LP reduced stake in above stock
Sold off
| Ticker | $ Sold |
|---|---|
| tonix pharmaceuticals hldg c | -217,630 |
| sagimet biosciences inc | -2,531,630 |
| fortress biotech inc | -1,219,420 |
| pepperlime health acqustn co | -11,062 |
| envveno medical corporation | -1,770,580 |
| diamedica therapeutics inc | -817,062 |
| tg venture acquisition corp | -2,960 |
| sadot group inc | -67,378 |
Altium Capital Management LP got rid off the above stocks
Sector Distribution
Altium Capital Management LP has about 84.6% of it's holdings in Healthcare sector.
| Sector | % |
|---|---|
| Healthcare | 84.6 |
| Others | 13.5 |
| Consumer Cyclical | 1.8 |
Market Cap. Distribution
Altium Capital Management LP has about 0% of it's portfolio invested in the large-cap and mega-cap stocks.
| Category | % |
|---|---|
| MID-CAP | 40.4 |
| SMALL-CAP | 30 |
| MICRO-CAP | 14.7 |
| UNALLOCATED | 13.5 |
| NANO-CAP | 1.4 |
Stocks belong to which Index?
About 54.3% of the stocks held by Altium Capital Management LP either belong to S&P 500 or RUSSELL 2000 index.
| Index | % |
|---|---|
| RUSSELL 2000 | 54.3 |
| Others | 45.7 |
Altium Capital Management LP Holdings Map
This heatmap illustrates the top 50 positions within the fund's portfolio.
Current Stock Holdings of Altium Capital Management LP
Altium Capital Management LP has 68 stocks in it's portfolio. About 46.9% of the portfolio is in top 10 stocks. SPRB proved to be the most loss making stock for the portfolio. VERA was the most profitable stock for Altium Capital Management LP last quarter.
Last Reported on: 15 May, 2024| Ticker | Namesorted ascending | % Portfolio | Shares Held | $ Value | Type | % Change | Options | |
|---|---|---|---|---|---|---|---|---|
| ACHV | achieve life sciences inc | 1.50 | 835,470 | 3,797,210 | new | |||
| ACT | advisorshares tr | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| ADMA | adma biologics inc | 4.02 | 1,540,000 | 10,164,000 | added | 40.64 | ||
| ALIM | alimera sciences inc | 3.94 | 2,550,000 | 9,945,000 | reduced | -4.14 | ||
| ALPN | alpine immune sciences inc | 1.22 | 77,848 | 3,085,900 | reduced | -1.11 | ||
| AMLX | amylyx pharmaceuticals inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| AQST | aquestive therapeutics inc | 1.12 | 665,000 | 2,832,900 | new | |||
| ARVN | arvinas inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| ASND | ascendis pharma a/s | 1.50 | 25,000 | 3,779,250 | unchanged | 0.00 | ||
| ATXS | astria therapeutics inc | 0.79 | 142,532 | 2,006,140 | reduced | -80.48 | ||
| AVDL | avadel pharmaceuticals plc | 3.70 | 553,057 | 9,341,130 | new | |||
| AXSM | axsome therapeutics inc | 4.36 | 138,000 | 11,012,400 | unchanged | 0.00 | ||
| BIVI | biovie inc | 0.63 | 3,012,610 | 1,592,460 | new | |||
| BOB | ea series trust | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| BRSH | bruush oral care inc | 0.00 | 14,423 | 110 | unchanged | 0.00 | ||
| CBAY | cymabay therapeutics inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| CEAD | cea industries inc | 0.00 | 250,000 | 3,250 | unchanged | 0.00 | ||
| CING | cingulate inc | 0.00 | 270,000 | 5,697 | unchanged | 0.00 | ||
| CPRX | catalyst pharmaceuticals inc | 3.15 | 500,000 | 7,970,000 | added | 29.87 | ||
| CRNX | crinetics pharmaceuticals in | 0.00 | 0.00 | 0.00 | sold off | -100 | ||